Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

WALGREENS BOOTS ALLIANCE, INC.

(WBA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Walgreens : Now Administering COVID-19 Vaccinations in 49 States, Washington, D.C. and Puerto Rico

04/12/2021 | 09:31am EDT

Company surpasses 11 million COVID-19 vaccines administered, continues to expand access in medically underserved communities

Walgreens is now administering COVID-19 vaccines at a majority of its stores in 49 states, Washington, D.C. and Puerto Rico, as the company continues to play an integral role in the nation’s vaccination and pandemic response efforts. With the initiative to vaccinate residents and staff in long-term care facilities nearly complete, close to 60,000 immunizers are now administering vaccinations at more than 7,000 Walgreens stores and through off-site clinics. The company has administered more than 11 million COVID-19 vaccinations to date.

“Now more than ever, our pharmacy teams are there for our patients and customers, administering COVID-19 vaccinations to protect communities across the country at a critical time,” said John Standley, president, Walgreens. “As more vaccine becomes available, and more states and jurisdictions expand eligibility, we’re continuing to broaden access across our retail locations. We’re also driving equitable access to vaccines within underserved communities, to help the nation emerge from this pandemic.”

Walgreens began administering COVID-19 vaccinations as part of the Centers for Disease Control and Prevention (CDC) Pharmacy Partnership for Long-Term Care Program on Dec. 21. The company continues to accelerate vaccine efforts according to state and federal jurisdiction distribution plans, including the Federal Retail Pharmacy Program, which began in February.

Walgreens focus on ensuring equitable access to COVID-19 vaccines also continues. Through retail locations in medically underserved areas and areas with a high social vulnerability index score, as well as through COVID-19 vaccine clinics off-site, Walgreens is delivering vaccinations directly to some of the nation’s most vulnerable individuals.

Walgreens has conducted nearly 500 COVID-19 vaccine clinics to date in underserved areas across the country, including locations in California, Illinois, Georgia and Mississippi. Hundreds more off-site clinics are planned for the months ahead with partners including Uber, local community organizations, and most recently, national partners including the 100 Black Men of America Inc., and the National Coalition of 100 Black Women, Inc. From Houston and Chicago to Milwaukee and El Paso, Walgreens is working in collaboration with partners on the ground to accelerate equitable access and to remove transportation barriers for individuals hardest hit by the pandemic.

Supply of COVID-19 vaccines remains limited at this time and available by appointment only. Individuals eligible to receive COVID-19 vaccines vary per state and can schedule appointments by visiting Walgreens.com/ScheduleVaccine or by calling 1-800-WALGREENS, with scheduling options available in English and Spanish.

More information on Walgreens efforts to support communities during the COVID-19 pandemic is available here.

Additional imagery, b-roll and multimedia assets are available on the Walgreens newsroom.

About Walgreens

Walgreens (www.walgreens.com) is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a global leader in retail and wholesale pharmacy. As America’s most loved pharmacy, health and beauty company, Walgreens purpose is to champion the health and wellbeing of every community in America. Operating more than 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving approximately 8 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with platforms bringing together physical and digital, supported by the latest technology to deliver high-quality products and services in local communities nationwide.


© Business Wire 2021
All news about WALGREENS BOOTS ALLIANCE, INC.
05/07WALGREENS BOOTS ALLIANCE  : Commits $350,000 to Help Address Critical COVID-19 N..
BU
05/07WALGREENS BOOTS ALLIANCE  : - COVID-19 Vaccine Helps Alleviate Pandemic Fears an..
AQ
05/06Walmart Health To Acquire Telehealth Provider MeMD -- 4th Update
DJ
05/06Walmart Health To Acquire Telehealth Provider MeMD -- 3rd Update
DJ
05/06WALGREENS BOOTS ALLIANCE  : Introduces Mobile Clinics, Same-day Appointments Acr..
AQ
05/06WALGREENS BOOTS ALLIANCE  : COVID-19 Vaccine Helps Alleviate Pandemic Fears and ..
BU
05/06QUIDEL  : Taps Walgreens to Offer Its At-Home COVID-19 Test
MT
05/05Correction to May 4 Article on GE, AT&T CEO Pay Plans
DJ
05/04General Electric, AT&T Investors Reject CEO Pay Plans -- 3rd Update
DJ
05/04General Electric, AT&T Investors Reject CEO Pay Plans -- 2nd Update
DJ
More news
Financials (USD)
Sales 2021 133 B - -
Net income 2021 2 144 M - -
Net Debt 2021 8 805 M - -
P/E ratio 2021 19,6x
Yield 2021 3,51%
Capitalization 47 135 M 47 135 M -
EV / Sales 2021 0,42x
EV / Sales 2022 0,40x
Nbr of Employees 277 000
Free-Float 61,0%
Chart WALGREENS BOOTS ALLIANCE, INC.
Duration : Period :
Walgreens Boots Alliance, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 54,94 $
Last Close Price 54,53 $
Spread / Highest target 32,0%
Spread / Average Target 0,76%
Spread / Lowest Target -23,0%
EPS Revisions
Managers and Directors
NameTitle
Rosalind Gates Brewer Chief Executive Officer & Director
James Kehoe Global Chief Financial Officer & Executive VP
Stefano Pessina Executive Chairman
Francesco Tinto Global Chief Information Officer & Senior VP
Ornella Barra Co-Chief Operating Officer
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIANCE, INC.36.56%47 135
JD HEALTH INTERNATIONAL INC.-23.13%47 274
MCKESSON CORPORATION13.62%31 222
CARDINAL HEALTH, INC.5.56%17 080
HUADONG MEDICINE CO., LTD64.08%11 854
SINOPHARM GROUP CO., LTD.28.31%9 724